Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma
The Type 1 PI3Kinases comprise a family of enzymes, which primarily phosphorylate PIP2 to give the second messenger PIP3, a key player in many intracellular signaling processes [Science, 2002, 296, 1655; Trends Pharmacol. Sci.2003, 24, 366]. Of the four type 1 PI3Ks, the gamma-isoform, which is expr...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2007-02, Vol.17 (3), p.756-760 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 760 |
---|---|
container_issue | 3 |
container_start_page | 756 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 17 |
creator | Lanni, Jr, Thomas B Greene, Keri L Kolz, Christine N Para, Kimberly S Visnick, Melean Mobley, James L Dudley, David T Baginski, Theodore J Liimatta, Marya B |
description | The Type 1 PI3Kinases comprise a family of enzymes, which primarily phosphorylate PIP2 to give the second messenger PIP3, a key player in many intracellular signaling processes [Science, 2002, 296, 1655; Trends Pharmacol. Sci.2003, 24, 366]. Of the four type 1 PI3Ks, the gamma-isoform, which is expressed almost exclusively in leukocytes [Curr. Biol., 1997, 7, R470], is of particular interest with respect to its role in inflammatory diseases such as rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD) [Mol. Med. Today, 2000, 6, 347]. Investigation of a series of 4,6-disubstituted-4H-benzo[1,4]oxazin-3-ones has led to the identification of single-digit nanomolar inhibitors of PI3Kgamma, several of which had good cell based activity and were shown to be active in vivo in an aspectic peritonitis model of inflammatory cell migration. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68939947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68939947</sourcerecordid><originalsourceid>FETCH-LOGICAL-p547-ee4610cf8b5c9ecd81b0abb99771c223b2f356a4516795991cf6c16a271fc0a3</originalsourceid><addsrcrecordid>eNo1kF1LwzAYhXOhuDn9C5IrrywkTZo0lzK_hgMFvRBEypvs7Rppk9p04PbrHTqvDgee51ycIzJlRrGsNPJtQk5T-mSMSyblCZlwzUyR53pK4AaTXwcKYUXTNozNviYaa9o3GHBsti21GHbxnV_Jj_gNOx8wE1kMmCgk2scRw0h9aLz1Yxx-1eeFePQBEq6h6-CMHNfQJjw_5Iy83N2-zh-y5dP9Yn69zPpC6gxRKs5cXdrCGXSrklsG1hqjNXd5Lmxei0KBLLjSpjCGu1o5riDXvHYMxIxc_q32Q_zaYBqrzieHbQsB4yZVqjTCGKn34MUB3NgOV1U_-A6GbfV_ifgB6s5c2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68939947</pqid></control><display><type>article</type><title>Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lanni, Jr, Thomas B ; Greene, Keri L ; Kolz, Christine N ; Para, Kimberly S ; Visnick, Melean ; Mobley, James L ; Dudley, David T ; Baginski, Theodore J ; Liimatta, Marya B</creator><creatorcontrib>Lanni, Jr, Thomas B ; Greene, Keri L ; Kolz, Christine N ; Para, Kimberly S ; Visnick, Melean ; Mobley, James L ; Dudley, David T ; Baginski, Theodore J ; Liimatta, Marya B</creatorcontrib><description>The Type 1 PI3Kinases comprise a family of enzymes, which primarily phosphorylate PIP2 to give the second messenger PIP3, a key player in many intracellular signaling processes [Science, 2002, 296, 1655; Trends Pharmacol. Sci.2003, 24, 366]. Of the four type 1 PI3Ks, the gamma-isoform, which is expressed almost exclusively in leukocytes [Curr. Biol., 1997, 7, R470], is of particular interest with respect to its role in inflammatory diseases such as rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD) [Mol. Med. Today, 2000, 6, 347]. Investigation of a series of 4,6-disubstituted-4H-benzo[1,4]oxazin-3-ones has led to the identification of single-digit nanomolar inhibitors of PI3Kgamma, several of which had good cell based activity and were shown to be active in vivo in an aspectic peritonitis model of inflammatory cell migration.</description><identifier>ISSN: 0960-894X</identifier><identifier>PMID: 17095227</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Baculoviridae - drug effects ; Baculoviridae - enzymology ; Class Ib Phosphatidylinositol 3-Kinase ; Drug Design ; Drug Evaluation, Preclinical ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - pharmacology ; Escherichia coli - drug effects ; Indicators and Reagents ; Isoenzymes - antagonists & inhibitors ; Isoenzymes - genetics ; Magnetic Resonance Spectroscopy ; Mice ; Mice, Knockout ; Oxazines - chemical synthesis ; Oxazines - pharmacology ; Phosphatidylinositol 3-Kinases - antagonists & inhibitors ; Phosphatidylinositol 3-Kinases - genetics</subject><ispartof>Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.756-760</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17095227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lanni, Jr, Thomas B</creatorcontrib><creatorcontrib>Greene, Keri L</creatorcontrib><creatorcontrib>Kolz, Christine N</creatorcontrib><creatorcontrib>Para, Kimberly S</creatorcontrib><creatorcontrib>Visnick, Melean</creatorcontrib><creatorcontrib>Mobley, James L</creatorcontrib><creatorcontrib>Dudley, David T</creatorcontrib><creatorcontrib>Baginski, Theodore J</creatorcontrib><creatorcontrib>Liimatta, Marya B</creatorcontrib><title>Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The Type 1 PI3Kinases comprise a family of enzymes, which primarily phosphorylate PIP2 to give the second messenger PIP3, a key player in many intracellular signaling processes [Science, 2002, 296, 1655; Trends Pharmacol. Sci.2003, 24, 366]. Of the four type 1 PI3Ks, the gamma-isoform, which is expressed almost exclusively in leukocytes [Curr. Biol., 1997, 7, R470], is of particular interest with respect to its role in inflammatory diseases such as rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD) [Mol. Med. Today, 2000, 6, 347]. Investigation of a series of 4,6-disubstituted-4H-benzo[1,4]oxazin-3-ones has led to the identification of single-digit nanomolar inhibitors of PI3Kgamma, several of which had good cell based activity and were shown to be active in vivo in an aspectic peritonitis model of inflammatory cell migration.</description><subject>Animals</subject><subject>Baculoviridae - drug effects</subject><subject>Baculoviridae - enzymology</subject><subject>Class Ib Phosphatidylinositol 3-Kinase</subject><subject>Drug Design</subject><subject>Drug Evaluation, Preclinical</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Escherichia coli - drug effects</subject><subject>Indicators and Reagents</subject><subject>Isoenzymes - antagonists & inhibitors</subject><subject>Isoenzymes - genetics</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Oxazines - chemical synthesis</subject><subject>Oxazines - pharmacology</subject><subject>Phosphatidylinositol 3-Kinases - antagonists & inhibitors</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><issn>0960-894X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kF1LwzAYhXOhuDn9C5IrrywkTZo0lzK_hgMFvRBEypvs7Rppk9p04PbrHTqvDgee51ycIzJlRrGsNPJtQk5T-mSMSyblCZlwzUyR53pK4AaTXwcKYUXTNozNviYaa9o3GHBsti21GHbxnV_Jj_gNOx8wE1kMmCgk2scRw0h9aLz1Yxx-1eeFePQBEq6h6-CMHNfQJjw_5Iy83N2-zh-y5dP9Yn69zPpC6gxRKs5cXdrCGXSrklsG1hqjNXd5Lmxei0KBLLjSpjCGu1o5riDXvHYMxIxc_q32Q_zaYBqrzieHbQsB4yZVqjTCGKn34MUB3NgOV1U_-A6GbfV_ifgB6s5c2w</recordid><startdate>20070201</startdate><enddate>20070201</enddate><creator>Lanni, Jr, Thomas B</creator><creator>Greene, Keri L</creator><creator>Kolz, Christine N</creator><creator>Para, Kimberly S</creator><creator>Visnick, Melean</creator><creator>Mobley, James L</creator><creator>Dudley, David T</creator><creator>Baginski, Theodore J</creator><creator>Liimatta, Marya B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20070201</creationdate><title>Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma</title><author>Lanni, Jr, Thomas B ; Greene, Keri L ; Kolz, Christine N ; Para, Kimberly S ; Visnick, Melean ; Mobley, James L ; Dudley, David T ; Baginski, Theodore J ; Liimatta, Marya B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p547-ee4610cf8b5c9ecd81b0abb99771c223b2f356a4516795991cf6c16a271fc0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Baculoviridae - drug effects</topic><topic>Baculoviridae - enzymology</topic><topic>Class Ib Phosphatidylinositol 3-Kinase</topic><topic>Drug Design</topic><topic>Drug Evaluation, Preclinical</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Escherichia coli - drug effects</topic><topic>Indicators and Reagents</topic><topic>Isoenzymes - antagonists & inhibitors</topic><topic>Isoenzymes - genetics</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Oxazines - chemical synthesis</topic><topic>Oxazines - pharmacology</topic><topic>Phosphatidylinositol 3-Kinases - antagonists & inhibitors</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lanni, Jr, Thomas B</creatorcontrib><creatorcontrib>Greene, Keri L</creatorcontrib><creatorcontrib>Kolz, Christine N</creatorcontrib><creatorcontrib>Para, Kimberly S</creatorcontrib><creatorcontrib>Visnick, Melean</creatorcontrib><creatorcontrib>Mobley, James L</creatorcontrib><creatorcontrib>Dudley, David T</creatorcontrib><creatorcontrib>Baginski, Theodore J</creatorcontrib><creatorcontrib>Liimatta, Marya B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lanni, Jr, Thomas B</au><au>Greene, Keri L</au><au>Kolz, Christine N</au><au>Para, Kimberly S</au><au>Visnick, Melean</au><au>Mobley, James L</au><au>Dudley, David T</au><au>Baginski, Theodore J</au><au>Liimatta, Marya B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2007-02-01</date><risdate>2007</risdate><volume>17</volume><issue>3</issue><spage>756</spage><epage>760</epage><pages>756-760</pages><issn>0960-894X</issn><abstract>The Type 1 PI3Kinases comprise a family of enzymes, which primarily phosphorylate PIP2 to give the second messenger PIP3, a key player in many intracellular signaling processes [Science, 2002, 296, 1655; Trends Pharmacol. Sci.2003, 24, 366]. Of the four type 1 PI3Ks, the gamma-isoform, which is expressed almost exclusively in leukocytes [Curr. Biol., 1997, 7, R470], is of particular interest with respect to its role in inflammatory diseases such as rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD) [Mol. Med. Today, 2000, 6, 347]. Investigation of a series of 4,6-disubstituted-4H-benzo[1,4]oxazin-3-ones has led to the identification of single-digit nanomolar inhibitors of PI3Kgamma, several of which had good cell based activity and were shown to be active in vivo in an aspectic peritonitis model of inflammatory cell migration.</abstract><cop>England</cop><pmid>17095227</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.756-760 |
issn | 0960-894X |
language | eng |
recordid | cdi_proquest_miscellaneous_68939947 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Baculoviridae - drug effects Baculoviridae - enzymology Class Ib Phosphatidylinositol 3-Kinase Drug Design Drug Evaluation, Preclinical Enzyme Inhibitors - chemical synthesis Enzyme Inhibitors - pharmacology Escherichia coli - drug effects Indicators and Reagents Isoenzymes - antagonists & inhibitors Isoenzymes - genetics Magnetic Resonance Spectroscopy Mice Mice, Knockout Oxazines - chemical synthesis Oxazines - pharmacology Phosphatidylinositol 3-Kinases - antagonists & inhibitors Phosphatidylinositol 3-Kinases - genetics |
title | Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A11%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20and%20synthesis%20of%20phenethyl%20benzo%5B1,4%5Doxazine-3-ones%20as%20potent%20inhibitors%20of%20PI3Kinasegamma&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Lanni,%20Jr,%20Thomas%20B&rft.date=2007-02-01&rft.volume=17&rft.issue=3&rft.spage=756&rft.epage=760&rft.pages=756-760&rft.issn=0960-894X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68939947%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68939947&rft_id=info:pmid/17095227&rfr_iscdi=true |